Christopher Garabedian

Sarepta Therapeutics

Former President and Chief Executive Officer

Overview

Christopher Garabedian made an average of $5.1M in compensation at Sarepta Therapeutics from 2011 to 2015.

Annual data

2015

In 2015, Christopher Garabedian earned a total compensation of $4.5M as Former President and Chief Executive Officer at Sarepta Therapeutics.

Ranking1,845 out of 13,575
Percentile86.4%

Christopher Garabedian's 2015 compensation ranked 1,845th out of 13,575 executive pay records tracked by us this year.

Garabedian earned more than 86.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking184 out of 1,485
Percentile87.6%

In the industry group of Drugs, Garabedian's pay ranked 184th out of 1,485 executive pay records tracked by us in 2015.

Garabedian earned more than 87.6% of executives in this group.

Option Awards$3,878,006
Salary$152,559
Other$479,841
Total$4,510,407

Garabedian received $3.9M in option awards, which accounts for 85.98% of total compensation.

Garabedian also received $152.6K in salary and $479.8K in other compensation.

2014

In 2014, Christopher Garabedian earned a total compensation of $5M as Former President and Chief Executive Officer at Sarepta Therapeutics.

Ranking1,549 out of 12,903
Percentile88.0%

Christopher Garabedian's 2014 compensation ranked 1,549th out of 12,903 executive pay records tracked by us this year.

Garabedian earned more than 88.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking134 out of 1,313
Percentile89.8%

In the industry group of Drugs, Garabedian's pay ranked 134th out of 1,313 executive pay records tracked by us in 2014.

Garabedian earned more than 89.8% of executives in this group.

Non-Equity Incentive Plan$289,536
Option Awards$3,990,798
Salary$603,200
Other$119,492
Total$5,003,026

Garabedian received $4M in option awards, which accounts for 79.77% of total compensation.

Garabedian also received $289.5K in non-equity incentive plan, $603.2K in salary and $119.5K in other compensation.

2013

In 2013, Christopher Garabedian earned a total compensation of $9.7M as Former President and Chief Executive Officer at Sarepta Therapeutics.

Ranking429 out of 12,009
Percentile96.4%

Christopher Garabedian's 2013 compensation ranked 429th out of 12,009 executive pay records tracked by us this year.

Garabedian earned more than 96.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking21 out of 1,095
Percentile98.1%

In the industry group of Drugs, Garabedian's pay ranked 21st out of 1,095 executive pay records tracked by us in 2013.

Garabedian earned more than 98.1% of executives in this group.

Non-Equity Incentive Plan$362,500
Option Awards$8,576,970
Salary$580,000
Other$182,022
Total$9,701,492

Garabedian received $8.6M in option awards, which accounts for 88.41% of total compensation.

Garabedian also received $362.5K in non-equity incentive plan, $580K in salary and $182K in other compensation.

2012

In 2012, Christopher Garabedian earned a total compensation of $2.6M as Former President and Chief Executive Officer at Sarepta Therapeutics.

Ranking2,626 out of 11,067
Percentile76.3%

Christopher Garabedian's 2012 compensation ranked 2,626th out of 11,067 executive pay records tracked by us this year.

Garabedian earned more than 76.3% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking124 out of 858
Percentile85.5%

In the industry group of Drugs, Garabedian's pay ranked 124th out of 858 executive pay records tracked by us in 2012.

Garabedian earned more than 85.5% of executives in this group.

Non-Equity Incentive Plan$318,500
Option Awards$1,741,757
Salary$490,000
Stock Awards$73,500
Other$16,754
Total$2,640,511

Garabedian received $1.7M in option awards, which accounts for 65.96% of total compensation.

Garabedian also received $318.5K in non-equity incentive plan, $490K in salary, $73.5K in stock awards and $16.8K in other compensation.

2011

In 2011, Christopher Garabedian earned a total compensation of $3.9M as President and Chief Executive Officer at Sarepta Therapeutics.

Ranking1,485 out of 10,164
Percentile85.4%

Christopher Garabedian's 2011 compensation ranked 1,485th out of 10,164 executive pay records tracked by us this year.

Garabedian earned more than 85.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking69 out of 713
Percentile90.3%

In the industry group of Drugs, Garabedian's pay ranked 69th out of 713 executive pay records tracked by us in 2011.

Garabedian earned more than 90.3% of executives in this group.

Bonus$130,000
Non-Equity Incentive Plan$219,201
Option Awards$2,959,510
Salary$490,000
Other$59,099
Total$3,857,810

Garabedian received $3M in option awards, which accounts for 76.71% of total compensation.

Garabedian also received $130K in bonus, $219.2K in non-equity incentive plan, $490K in salary and $59.1K in other compensation.